Kwangdong Healthbio Co., Ltd. (XKON:086220)
South Korea
· Delayed Price · Currency is KRW 1,276.00
-9.00 (-0.70%)
Last updated: Dec 4, 2025, 2:25 PM KST
Kwangdong Healthbio Revenue
In the year 2014, Kwangdong Healthbio had annual revenue of 38.10B KRW with 19.85% growth.
Revenue
38.10B
Revenue Growth
-2.50%
P/S Ratio
0.36
Revenue / Employee
470.33M
Employees
81
Market Cap
13.75B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2014 | 38.10B | 6.31B | 19.85% |
| Dec 31, 2013 | 31.79B | -4.07B | -11.35% |
| Dec 31, 2012 | 35.86B | 6.04B | 20.27% |
| Dec 31, 2011 | 29.81B | -17.09B | -36.44% |
| Dec 31, 2010 | 46.91B | 527.66M | 1.14% |
| Dec 31, 2009 | Pro | Pro | Pro |
| Dec 31, 2008 | Pro | Pro | Pro |
| Dec 31, 2007 | Pro | Pro | Pro |
| Dec 31, 2006 | Pro | Pro | Pro |
| Dec 31, 2005 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 315.56T |
| SK hynix | 84.09T |
| LG Energy Solution | 23.98T |
| Samsung Biologics | 5,504.84B |
| Hyundai Motor Company | 186.04T |
| Doosan Enerbility | 16.79T |
| Kia Corporation | 113.20T |
| HD Hyundai Heavy Industries | 16.39T |